CompletedNot Applicable

CGM in Patients With ED's

United States50 participantsStarted 2023-05-09

Plain-language summary

To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ages 18-65 and meet the DSM-V criteria for AN-R or AN-BP or ARFID * Admission %IBW ≤ 75% Exclusion Criteria: * Diagnosed with an eating disorder other than AN-R or AN-BP or ARFID * %IBW \> 75% on admission * Inability to give informed consent to participate/lacks decisional capacity * Unable to follow the study protocol * Transferred to the unit on a mental health hold/short term certification * Treatment team refusal of patient's participation

What they're measuring

Determine the accuracy of continuous glucose monitors (CGM)

Timeframe: 10 days

Serum glucose fluctuations

Timeframe: 10 days

Frequency of hypoglycemia

Timeframe: 10 days

Trial details

NCT IDNCT05603481

SponsorDenver Health and Hospital Authority

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-01

View on ClinicalTrials.gov More Anorexia Nervosa Restricting Type trials